PUBLISHER: Market Research Future | PRODUCT CODE: 1517288
PUBLISHER: Market Research Future | PRODUCT CODE: 1517288
Europe Enteral Feeding Market Research Report Information by Type (Feeding Pump, Feeding Tube, Nasoenteric Feeding Tubes, Enteral Syringes, Administration Sets, and Consumables), by Age Group (adult, and pediatric), by Application (Oncology, Diabetes, Hypermetabolism, Neurological Disorder, and Others), by end user (hospital, home care, and ambulatory surgery centers)-Forecast to 2030
It is anticipated that the Europe Enteral Feeding Market will experience a substantial compound annual growth rate (CAGR) of 16.18% during the review period. The Europe enteral feeding market is experiencing growth because of the increasing prevalence of chronic diseases, the transition from parental nutrition to enteral nutrition, and the rising incidence of preterm births. Nevertheless, the market is also impeded by the complications associated with enteral nutrition devices and the insufficient reimbursement policies. However, it is expected that the European enteral feeding market will generate profitable opportunities for participants due to the expanded availability of home enteral nutrition.
Enteral feeding, which includes oral and tube feeding, is the process of ingesting sustenance through the digestive system. Typically, these feedings are administered when an individual is unable to meet their body's nutritional needs. The nasogastric tube (NGT), orogastric tube (OGT), jejunostomy tube, nasoenteric tube, and oroenteric tube are the most frequently used enteral nutrition devices. These tubes ensure that patients receive the necessary nutrition for their bodies while simultaneously promoting the heath of their gastrointestinal systems.
Europe's enteral feeding market is divided into the following categories: feeding pumps, feeding tubes, nasoenteric feeding tubes, enteral syringes, administration systems, and consumables.
The Europe enteral nutrition market has been segmented into adult and pediatric categories based on age.
The Europe enteral nutrition market has been categorized as hypermetabolism, oncology, diabetes, neurological disorder, and others based on its application.
The Europe enteral feeding market has been categorized as ambulatory surgery centers, home care, and hospital based on the end user.
Germany, France, the United Kingdom, Italy, Spain, the Netherlands, the Nordics, and the Rest of Europe constitute the Europe region. The European enteral feeding market is primarily driven by the increasing prevalence of chronic diseases, advancements in enteral feeding devices, and the higher incidence of preterm births. The European Foundation for the Care of Newborn Infants reports that the prevalence rate of preterm birth in Europe is an average of 7.3% of all live births. Furthermore, preterm birth is one of the two most prevalent causes of neonatal mortality in Europe.
Fresenius Kabi AG (Germany) is the primary market player. Cardinal Health (US) is the second largest player in the market, followed by Danone S.A. (France), B. Braun SE (Germany), Avanos Medical, Inc. (US), Applied Medical Technology, Inc. (US), Boston Scientific Corporation (US), BD (US), Cook (US), Vygon (France), Applied Medical Technology, Inc. (US), and CONMED Corporation (US).